BillionToOne logo

BillionToOne

We push the boundaries of molecular diagnostics through quantitative technologies.

815 employees · est. 2016 · Menlo Park, United States

VS
Iontek Molecular Diagnostics logo

Iontek Molecular Diagnostics

Bringing Color to Molecular Diagnostics

1 employees · est. 1997 · Istanbul, Turkey

Iontek Molecular Diagnostics is the older company (2016 vs 1997); BillionToOne is the larger of the two.

Side-by-Side Comparison

BillionToOne Iontek Molecular Diagnostics
Founded
2016 1997 older
Headquarters
Menlo Park, United States Istanbul, Turkey
Employees
815 larger 1
Industry
Biotechnology, Health Care Digital Health, Health Care, Health and Wellness
Funding Stage
IPO Not tracked yet
Total Funding
$650.63M Not tracked yet
Funding Rounds
9 Not tracked yet
Services
Development and provision of advanced diagnostic tests, Quantification of disease-causing DNA fragments, Non-invasive prenatal and oncology testing solutions, Monitoring treatment response in cancer patients Oligonucleotide Production, DNA Sequencing Services, Real-Time PCR Kits, Sequencing Kits, Laboratory Services
Target Customers
Healthcare Providers, Pregnant Women, Oncologists, Medical Researchers Biotechnology Companies, Research and Development Organizations, Molecular Biology Labs, Healthcare Providers
Taxonomy
Molecular Diagnostics, Precision Diagnostics, DNA Quantification, Molecular Counting Technology, Disease Detection, Prenatal Testing, Single-gene Disorder Detection, Non-invasive Testing, Blood Test Innovation, Affordable Healthcare Solutions, Patent-pending Technology, Risk Reduction In Diagnostics, Biotechnology Innovation Molecular Diagnostics, Real-Time PCR, In Vitro Diagnostic Devices, Viral Disease Diagnosis, Hepatitis Diagnosis, HIV Diagnosis, DNA Production, DNA Sequencing, R&D In Biotechnology, Customized Diagnostic Solutions, Healthcare Innovation, Customer Support In Diagnostics, Microbiology Testing, Genetic Testing
Website
billiontoone.com iontek.com.tr
BillionToOne logo

About BillionToOne

BillionToOne, founded in 2016, is a pioneering entity in the Biotechnology and Health Care industries, headquartered in the United States. The company is renowned for its commitment to enhancing the accuracy, efficiency, and accessibility of molecular diagnostics, encapsulated in their slogan: "We p...

Iontek Molecular Diagnostics logo

About Iontek Molecular Diagnostics

Iontek Molecular Diagnostics, founded in 1997, stands out as a trailblazer in the molecular diagnostics sector within Turkey. Renowned for its commitment to quality, Iontek operates under stringent standards such as ISO 9001: 2015 and ISO 13485: 2016, ensuring high-quality outcomes in their molecula...

We will tell you when either one moves

BounceWatch watches BillionToOne and Iontek Molecular Diagnostics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BillionToOne and Iontek Molecular Diagn... — by email.

Frequently Asked Questions

BillionToOne — We push the boundaries of molecular diagnostics through quantitative technologies.. Iontek Molecular Diagnostics — Bringing Color to Molecular Diagnostics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BillionToOne has raised $650.63M while Iontek Molecular Diagnostics has raised undisclosed funding.
BillionToOne and Iontek Molecular Diagnostics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BillionToOne with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BillionToOne on 9 Jun 2026, and Iontek Molecular Diagnostics on 26 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy